Vera Therapeutics (VERA) had the highest return in January 2024 by a US stock with a market cap of $1B+, returning 139.6%.

ASSET	MONTH	% RETURN
Vera Therapeutics (VERA)	January 2024	139.61%
Trump Media & Technology (DJT)	January 2024	115.14%
Dave (DAVE)	January 2024	112.39%
Super Micro Computer (SMCI)	January 2024	89.15%
Arcutis Biotherapeutics (ARQT)	January 2024	85.17%
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS)	January 2024	82.77%
Sezzle Inc Common Stock (SEZL)	January 2024	80.91%
Flex (FLEX)	January 2024	74.41%
WM Technology (MAPSW)	January 2024	70%
Dyne Therapeutics (DYN)	January 2024	64.36%
Edgewise Therapeutics (EWTX)	January 2024	63.13%
Rumble (RUM)	January 2024	52.22%
Summit Therapeutics (SMMT)	January 2024	51.94%
ZIM Integrated Shipping Services (ZIM)	January 2024	44.23%
GeneDx (WGS)	January 2024	42.59%
Ardelyx (ARDX)	January 2024	42.18%
Oscar Health (OSCR)	January 2024	38.65%
Alvotech (ALVO)	January 2024	37.08%
Tarsus Pharmaceuticals (TARS)	January 2024	36.2%
Powell Industries (POWL)	January 2024	36.15%
Avidity Biosciences (RNA)	January 2024	35.59%
Advantage Solutions (ADVWW)	January 2024	32.01%
Merus (MRUS)	January 2024	31.61%
Viking Therapeutics (VKTX)	January 2024	30.28%
Innodata (INOD)	January 2024	29.63%